Browse Drug Recalls

12 FDA drug safety recalls.

FDA Drug Recall Enforcement Database

Browse 12 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.

Drug Safety Recalls

Browse 12 FDA drug recalls.

Clear
DateProductReasonClassFirm
Oct 8, 2025 Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syring... Lack of Assurance of Sterility: Class II ASTRAZENECA PHARMACEUTICALS
May 14, 2025 Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inh... Defective delivery system Class II AsttraZeneca Pharmaceuticals LP
Mar 15, 2021 Budesonide and Formoterol Fumarate Dihydrate Inhalation Aerosol 80/4.5 budeso... CGMP Deviations: Intermittent exposure to temperature excursion during storage. Class II Cardinal Health Inc.
Mar 15, 2021 xigduo XR (dapagliflozin/metformin HCl extended-release) tablets 5 mg/1000 mg... CGMP Deviations: Intermittent exposure to temperature excursion during storage. Class II Cardinal Health Inc.
Mar 15, 2021 xigduo XR (dapgliflozin/metformin HCl extended-release) tablets 10 mg/1000 mg... CGMP Deviations: Intermittent exposure to temperature excursion during storage. Class II Cardinal Health Inc.
Feb 23, 2018 Lynparza (olaparib) capsules 50 mg, 112 count bottles, Rx only, Manufactured ... Failed Impurities/Degradation Specifications; elevated levels of quality attribute Form L (polym... Class III AstraZeneca Pharmaceuticals LP
May 25, 2017 BRILINTA (ticagrelor) tablets, 90 mg, 8-count Professional Sample bottles, Rx... Presence of Foriegn Tablets/Capsules: customer complaint that an 8-count professional sample bott... Class I AstraZeneca Pharmaceuticals, LP
Feb 5, 2016 Tudorza Pressair (aclindinium bromide inhalation powder), 400 mcg per actuati... Defective Delivery System: Some units have actuation counters set to a number other than 60. Class II AstraZeneca Pharmaceuticals LP
Jun 10, 2015 NEXIUM¿ (esomeprazole magnesium), Delayed-Release capsules, 20 mg, 30-count b... Presence of Foreign Tablets/Capsules: Confimed customer compliant by a retail pharmacist that an ... Class II AstraZeneca Pharmaceuticals LP
Jun 21, 2013 MERREM I.V. (meropenem for injection), 1 g meropenem equivalent, 30 mL vial, ... Presence of Precipitate; potential for incomplete constitution upon addition of diluent. Class II AstraZeneca Pharmaceuticals LP
Jun 5, 2012 Kombiglyze XR (saxagliptin and metformin HCl extended-release) tablets, Physi... Labeling; Correct labeled product miscart/mispack: Some Physician sample cartons were incorrectly... Class II Bristol-myers Squibb Company
Jun 5, 2012 Kombiglyze XR (saxagliptin and metformin HCl extended-release) tablets, Physi... Labeling; Correct labeled product miscart/mispack: Some Physician sample cartons were incorrectly... Class II Bristol-myers Squibb Company

Frequently Asked Questions

When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.

The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.

Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.